uPAR Induces Expression of Transforming Growth Factor β and Interleukin-4 in Cancer Cells to Promote Tumor-Permissive Conditioning of Macrophages

Houghton, 2004, Gastric cancer originating from bone marrow-derived cells, Science, 306, 1568, 10.1126/science.1099513 Karin, 2006, Innate immunity gone awry: linking microbial infections to chronic inflammation and cancer, Cell, 124, 823, 10.1016/j.cell.2006.02.016 Kuper, 2000, Infections as a major preventable cause of human cancer, J Intern Med, 248, 171, 10.1046/j.1365-2796.2000.00742.x Vakkila, 2004, Inflammation and necrosis promote tumour growth, Nat Rev Immunol, 4, 641, 10.1038/nri1415 Coussens, 2002, Inflammation and cancer, Nature, 420, 860, 10.1038/nature01322 Condeelis, 2006, Macrophages: obligate partners for tumor cell migration, invasion, and metastasis, Cell, 124, 263, 10.1016/j.cell.2006.01.007 Wyckoff, 2004, A paracrine loop between tumor cells and macrophages is required for tumor cell migration in mammary tumors, Cancer Res, 64, 7022, 10.1158/0008-5472.CAN-04-1449 Lin, 2006, Macrophages regulate the angiogenic switch in a mouse model of breast cancer, Cancer Res, 66, 11238, 10.1158/0008-5472.CAN-06-1278 Lin, 2007, Tumor-associated macrophages press the angiogenic switch in breast cancer, Cancer Res, 67, 5064, 10.1158/0008-5472.CAN-07-0912 Balkwill, 2004, Cancer and the chemokine network, Nat Rev Cancer, 4, 540, 10.1038/nrc1388 Bates, 2006, Quantification of regulatory T cells enables the identification of high-risk breast cancer patients and those at risk of late relapse, J Clin Oncol, 24, 5373, 10.1200/JCO.2006.05.9584 DeNardo, 2009, CD4(+) T cells regulate pulmonary metastasis of mammary carcinomas by enhancing protumor properties of macrophages, Cancer Cell, 16, 91, 10.1016/j.ccr.2009.06.018 DeNardo, 2007, Inflammation and breast cancer. Balancing immune response: crosstalk between adaptive and innate immune cells during breast cancer progression, Breast Cancer Res, 9, 212, 10.1186/bcr1746 Lee, 1997, Angiogenesis and inflammation in invasive carcinoma of the breast, J Clin Pathol, 50, 669, 10.1136/jcp.50.8.669 Leek, 2002, Tumor-associated macrophages in breast cancer, J Mammary Gland Biol Neoplasia, 7, 177, 10.1023/A:1020304003704 Leek, 1996, Association of macrophage infiltration with angiogenesis and prognosis in invasive breast carcinoma, Cancer Res, 56, 4625 Volodko, 1998, Tumour-associated macrophages in breast cancer and their prognostic correlations, Breast, 7, 99, 10.1016/S0960-9776(98)90065-0 Mantovani, 2004, Tumour-associated macrophages as a prototypic type II polarised phagocyte population: role in tumour progression, Eur J Cancer, 40, 1660, 10.1016/j.ejca.2004.03.016 Mantovani, 2002, Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes, Trends Immunol, 23, 549, 10.1016/S1471-4906(02)02302-5 Van Ginderachter, 2006, Classical and alternative activation of mononuclear phagocytes: picking the best of both worlds for tumor promotion, Immunobiology, 211, 487, 10.1016/j.imbio.2006.06.002 Martinez, 2014, The M1 and M2 paradigm of macrophage activation: time for reassessment, F1000Prime Rep, 6, 13, 10.12703/P6-13 Bronte, 2005, Regulation of immune responses by L-arginine metabolism, Nat Rev Immunol, 5, 641, 10.1038/nri1668 Chang, 2001, Macrophage arginase promotes tumor cell growth and suppresses nitric oxide-mediated tumor cytotoxicity, Cancer Res, 61, 1100 Franklin, 2014, The cellular and molecular origin of tumor-associated macrophages, Science, 344, 921, 10.1126/science.1252510 Bianchi, 1994, The urokinase receptor is expressed in invasive breast cancer but not in normal breast tissue, Cancer Res, 54, 861 Cozzi, 2006, Evaluation of urokinase plasminogen activator and its receptor in different grades of human prostate cancer, Hum Pathol, 37, 1442, 10.1016/j.humpath.2006.05.002 Andreasen, 1997, The urokinase-type plasminogen activator system in cancer metastasis: a review, Int J Cancer, 72, 1, 10.1002/(SICI)1097-0215(19970703)72:1<1::AID-IJC1>3.0.CO;2-Z de Bock, 2004, Clinical significance of urokinase-type plasminogen activator receptor (uPAR) expression in cancer, Med Res Rev, 24, 13, 10.1002/med.10054 Blasi, 2002, uPAR: a versatile signalling orchestrator, Nat Rev Mol Cell Biol, 3, 932, 10.1038/nrm977 Nguyen, 1998, Binding of urokinase-type plasminogen activator to its receptor in MCF-7 cells activates extracellular signal-regulated kinase 1 and 2 which is required for increased cellular motility, J Biol Chem, 273, 5802, 10.1074/jbc.273.14.8502 Madsen, 2007, uPAR-induced cell adhesion and migration: vitronectin provides the key, J Cell Biol, 177, 927, 10.1083/jcb.200612058 Eastman, 2012, A transformation in the mechanism by which the urokinase receptor signals provides a selection advantage for estrogen receptor-expressing breast cancer cells in the absence of estrogen, Cell Signal, 24, 1847, 10.1016/j.cellsig.2012.05.011 Ma, 2001, Endogenously produced urokinase-type plasminogen activator is a major determinant of the basal level of activated ERK/MAP kinase and prevents apoptosis in MDA-MB-231 breast cancer cells, J Cell Sci, 114, 3387, 10.1242/jcs.114.18.3387 Ossowski, 2000, Urokinase receptor and integrin partnership: coordination of signaling for cell adhesion, migration and growth, Curr Opin Cell Biol, 12, 613, 10.1016/S0955-0674(00)00140-X Kjøller, 2001, Rac mediates cytoskeletal rearrangements and increased cell motility induced by urokinase-type plasminogen activator receptor binding to vitronectin, J Cell Biol, 152, 1145, 10.1083/jcb.152.6.1145 Lester, 2007, uPAR induces epithelial-mesenchymal transition in hypoxic breast cancer cells, J Cell Biol, 178, 425, 10.1083/jcb.200701092 Jo, 2009, The urokinase receptor promotes cancer metastasis independently of urokinase-type plasminogen activator in mice, Am J Pathol, 175, 190, 10.2353/ajpath.2009.081053 Jo, 2010, Cell signaling by urokinase-type plasminogen activator receptor induces stem cell-like properties in breast cancer cells, Cancer Res, 70, 8948, 10.1158/0008-5472.CAN-10-1936 Hu, 2011, Crosstalk between the urokinase-type plasminogen activator receptor and EGF receptor variant III supports survival and growth of glioblastoma cells, Proc Natl Acad Sci USA, 108, 15984, 10.1073/pnas.1113416108 Staudt, 2013, Myeloid cell receptor LRP1/CD91 regulates monocyte recruitment and angiogenesis in tumors, Cancer Res, 73, 3902, 10.1158/0008-5472.CAN-12-4233 Mukasa, 2010, Mutant EGFR is required for maintenance of glioma growth in vivo, and its ablation leads to escape from receptor dependence, Proc Natl Acad Sci USA, 107, 2616, 10.1073/pnas.0914356107 Zhang, 2008, The isolation and characterization of murine macrophages, Curr Protoc Immunol, 10.1002/0471142735.im1401s83 Kepka-Lenhart, 2008, Determination of mammalian arginase activity, Methods Enzymol, 440, 221, 10.1016/S0076-6879(07)00813-0 Aslakson, 1992, Selective events in the metastatic process defined by analysis of the sequential dissemination of subpopulations of a mouse mammary tumor, Cancer Res, 52, 1399 Mi, 2006, Integrin-linked kinase regulates osteopontin-dependent MMP-2 and uPA expression to convey metastatic function in murine mammary epithelial cancer cells, Carcinogenesis, 27, 1134, 10.1093/carcin/bgi352 Flavell, 2010, The polarization of immune cells in the tumour environment by TGFbeta, Nat Rev Immunol, 10, 554, 10.1038/nri2808 Harthun, 1998, Activated alpha 2-macroglobulin reverses the immunosuppressive activity in human breast cancer cell-conditioned medium by selectively neutralizing transforming growth factor-beta in the presence of interleukin-2, J Immunother, 21, 85, 10.1097/00002371-199803000-00001 Standiford, 2011, TGF-beta-induced IRAK-M expression in tumor-associated macrophages regulates lung tumor growth, Oncogene, 30, 2475, 10.1038/onc.2010.619 Luo, 2012, Mouse forestomach carcinoma cells immunosuppress macrophages through transforming growth factor-β1, Mol Med Rep, 5, 988, 10.3892/mmr.2012.777 Peng, 2013, Inhibition of TGF-β signaling in combination with TLR7 ligation re-programs a tumoricidal phenotype in tumor-associated macrophages, Cancer Lett, 331, 239, 10.1016/j.canlet.2013.01.001 Odekon, 1994, Requirement for receptor-bound urokinase in plasmin-dependent cellular conversion of latent TGF-beta to TGF-beta, J Cell Physiol, 158, 398, 10.1002/jcp.1041580303 Gerwin, 1990, TGF-beta 1 modulation of urokinase and PAI-1 expression in human bronchial epithelial cells, Am J Physiol, 259, L262 Webb, 2001, Plasminogen activator inhibitor 1 functions as a urokinase response modifier at the level of cell signaling and thereby promotes MCF-7 cell growth, J Cell Biol, 152, 741, 10.1083/jcb.152.4.741 Taylor, 2012, Targeting EGFR for treatment of glioblastoma: molecular basis to overcome resistance, Curr Cancer Drug Targets, 12, 197, 10.2174/156800912799277557